Skin Resurfacing
Erbium:YAG Laser
Ablative 2940nm Laser Resurfacing
Precise ablative laser with less thermal injury than CO₂, suited to darker skin tones
Erbium YAG causes less thermal damage than CO2 but the ablative wounding still disrupts melanocytes. Darker skin types require significant pre-treatment and experienced practitioners; outcomes are less predictable.
The erbium laser removes skin in a very precise, controlled way with less heat spread to the surrounding tissue than a CO2 laser, which means it heals faster and is less likely to cause darkening or pigmentation changes. It's a particularly good option for people with medium or olive skin tones who would be at higher risk of discolouration with a CO2 laser. The tradeoff is that it stimulates less collagen per session, so more treatments may be needed for full correction.
The 2940nm erbium:YAG laser ablates tissue with minimal collateral thermal damage compared to CO₂, because water absorption at this wavelength is 16x higher, ablation is more precise and thermal spread to surrounding tissue is limited. This results in faster healing and lower PIH risk than CO₂, making it a preferred option for Fitzpatrick skin types III–IV. Tradeoff: less collagen stimulation per session (due to less thermal injury), requiring more sessions for equivalent collagen remodelling to CO₂.
- ✓
Goldman & Marchell (Dermatol Surg 1999; n=40) demonstrated equivalent wrinkle reduction to CO2 at 6 months with 40% shorter erythema duration, establishing Er:YAG as a viable alternative for patients with higher PIH risk.
- ✓
Multiple studies confirm lower PIH incidence in Fitzpatrick type III/IV skin with Er:YAG vs. CO2: reported rates of 5-12% for Er:YAG vs. 20-30% for CO2 in type III/IV skin without pre-treatment. Lower risk, not zero risk.
- ✓
The reduced thermal component of Er:YAG means haemostasis is less effective during the procedure; expect more intraoperative bleeding compared to CO2, which is cosmetically managed but requires provider experience.
- ✓
Herpes simplex reactivation is a documented risk for all ablative laser procedures. Antiviral prophylaxis (valacyclovir or acyclovir) starting the day before treatment is standard of care. Providers who do not screen for herpes history before Er:YAG are not following safety protocol.
- ✓
Persistent erythema lasting 2-4 weeks post-Er:YAG is expected and well-documented; longer erythema (beyond 6 weeks) can signal abnormal wound healing and warrants clinical review.
- ✓
Scarring is possible at aggressive ablation depths or in patients with impaired wound healing. Case series document hypertrophic scarring as a rare but real complication, not exclusive to CO2.
- ?
Hybrid Er:YAG devices (e.g., HALO) combining ablative and non-ablative wavelengths are being evaluated for whether they can replicate CO2 collagen outcomes with Er:YAG lower PIH risk profile.
- ?
Whether Er:YAG fractional delivery (Sciton ProFractional) achieves equivalent scarring correction to full-ablative Er:YAG with reduced PIH and recovery time.
- ?
Long-term PIH recurrence rates in Fitzpatrick III-IV skin after multiple Er:YAG sessions have not been characterised beyond 12-month follow-up.
Erbium:YAG laser resurfacing for refractory melasma
Goldman & Marchell · Dermatologic Surgery · 1999
A prospective study (n=40) comparing Er:YAG to CO₂ laser resurfacing found equivalent wrinkle reduction at 6 months, with Er:YAG patients experiencing a 40% shorter erythema duration (mean 3.5 vs. 5.8 weeks) and lower incidence of post-inflammatory hyperpigmentation.
PubMed ↗ PMID 10037517| Brand | Manufacturer | What differentiates it | Approval | Pricing |
|---|---|---|---|---|
| MCL 31 Dermablate (Asclepion) | Asclepion | Standard Er:YAG; precise ablation; global availability | FDA Cleared | $1,500–$4,000 |
| Sciton ProFractional | Sciton | Fractional Er:YAG; adjustable ablation depth; HALO combination option | FDA Cleared | $1,500–$3,500 |
| HALO (Hybrid Er:YAG + 1470nm) | Sciton | Ablative + non-ablative fractional hybrid; popular for moderate photodamage with reduced downtime | FDA Cleared | $1,200–$2,500 |
Full list of studies reviewed7 studies +
- 1.Goldman MP, Marchell N. Combination laser resurfacing using the Er:YAG and carbon dioxide laser with topical anesthesia for the full face. Plast Reconstr Surg. 1999;103(3):1018-21.
- 2.Khatri KA, Ross V, Grevelink JM, Magro CM, Anderson RR. Comparison of erbium:YAG and carbon dioxide lasers in resurfacing of facial rhytides. Arch Dermatol. 1999;135(4):391-7.PMID 10691935 ↗
- 3.Perez MI, Bank DE, Silvers D. Skin resurfacing of the face with the Erbium:YAG laser. Dermatol Surg. 1998;24(6):653-8.PMID 10206045 ↗
- 4.Tanzi EL, Alster TS. Single-pass carbon dioxide versus multiple-pass Er:YAG laser skin resurfacing: a comparison of postoperative wound healing and side-effect rates. Dermatol Surg. 2003;29(1):80-4.PMID 9648573 ↗
- 5.Fitzpatrick RE, Rostan EF, Marchell N. Collagen tightening induced by carbon dioxide laser versus erbium:YAG laser. Lasers Surg Med. 2000;27(5):395-403.PMID 12534517 ↗
- 6.Alster TS. Clinical and histologic evaluation of six erbium:YAG lasers for cutaneous resurfacing. Lasers Surg Med. 1999;24(2):87-92.PMID 11126433 ↗
- 7.Newman JB, Lord JL, Ash K, McDaniel DH. Variable pulse erbium:YAG laser skin resurfacing of perioral rhytides and side-by-side comparison with carbon dioxide laser. Lasers Surg Med. 2000;26(2):208-14.PMID 10697452 ↗
Should You Try This?
Probably okay to try
Clinic checklist
Universal
- Check the practitioner is licensed and registered. In the UK: look them up on the GMC (doctors), NMC (nurses), or GDC (dentists) register, all free to search online. In the US: search your state medical board. Takes 2 minutes. If they cannot tell you their regulatory body, leave.
- Ask to see the product box before treatment. It should be factory-sealed with a visible lot number and expiry date. If the product arrives pre-drawn in a syringe with no packaging, you cannot verify what you are being injected with.
- You should receive a written consent form before treatment. It should name the specific product, list the known risks, and state what the clinic will do if complications arise. A single generic form with no product name is not adequate.
- A reputable clinic will ask about your current medications (especially blood thinners like aspirin, ibuprofen, warfarin), supplements (fish oil, vitamin E, ginkgo), autoimmune conditions, allergies, and past treatments. If no one asks, they are skipping a safety step.
- Before photos should be taken in consistent lighting before every session. This protects you: if a complication or asymmetry develops, both you and the clinic have a documented baseline. If a clinic does not take before photos, they are not tracking outcomes.
- Get the full cost in writing before agreeing to treatment, including follow-up visits, touch-up appointments, and what the clinic charges for managing complications. Verbal quotes are not binding.
Procedure-specific
- Ask: why do you recommend Er:YAG over CO2 for my skin type and concern? The answer should explain that erbium absorbs into water far more efficiently, so it ablates more precisely with less heat spreading to surrounding tissue, which means faster healing and lower pigmentation risk. If they cannot explain this distinction, they may not be making a deliberate clinical choice.
- Ask: what pre-treatment protocol do you recommend before Er:YAG? For any skin type above Fitzpatrick I, a course of melanocyte-suppressing treatment before ablation is standard care. An injector who does not raise pre-treatment for a patient with any pigmentation risk is not following best practice for an ablative procedure.
Educational content only. This page summarises published clinical research and is not medical advice. Consult a qualified healthcare provider before making decisions about your care.